JP2023505513A5 - - Google Patents

Info

Publication number
JP2023505513A5
JP2023505513A5 JP2022534425A JP2022534425A JP2023505513A5 JP 2023505513 A5 JP2023505513 A5 JP 2023505513A5 JP 2022534425 A JP2022534425 A JP 2022534425A JP 2022534425 A JP2022534425 A JP 2022534425A JP 2023505513 A5 JP2023505513 A5 JP 2023505513A5
Authority
JP
Japan
Prior art keywords
alkyl
bis
hydrogen
dimethylocta
dien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022534425A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505513A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051638 external-priority patent/WO2021113958A1/en
Publication of JP2023505513A publication Critical patent/JP2023505513A/ja
Publication of JP2023505513A5 publication Critical patent/JP2023505513A5/ja
Pending legal-status Critical Current

Links

JP2022534425A 2019-12-09 2020-11-27 カンナビノイド誘導体 Pending JP2023505513A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962945669P 2019-12-09 2019-12-09
US62/945,669 2019-12-09
US202063074603P 2020-09-04 2020-09-04
US63/074,603 2020-09-04
US202063112970P 2020-11-12 2020-11-12
US63/112,970 2020-11-12
PCT/CA2020/051638 WO2021113958A1 (en) 2019-12-09 2020-11-27 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2023505513A JP2023505513A (ja) 2023-02-09
JP2023505513A5 true JP2023505513A5 (cg-RX-API-DMAC10.html) 2023-11-22

Family

ID=76329189

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022534425A Pending JP2023505513A (ja) 2019-12-09 2020-11-27 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20230059582A1 (cg-RX-API-DMAC10.html)
EP (1) EP4073033A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023505513A (cg-RX-API-DMAC10.html)
WO (1) WO2021113958A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3994114A4 (en) 2019-07-04 2023-08-16 Canopy Growth Corporation CANNABINOID DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
WO2021007661A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12084407B2 (en) 2019-11-26 2024-09-10 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12617765B2 (en) 2019-12-09 2026-05-05 Canopy Growth Corporation Cannabinoid derivatives
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use
TWI894435B (zh) * 2021-02-26 2025-08-21 日商丸善石油化學股份有限公司 縮醛化合物、含有該化合物之添加劑及含有該化合物之阻劑用組成物
AU2022324615A1 (en) * 2021-08-04 2024-02-15 Demeetra Agbio, Inc. Cannabinoid derivatives and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009807A2 (en) * 2001-07-23 2003-02-06 Galileo Laboratories, Inc. Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
US8481085B2 (en) * 2006-06-15 2013-07-09 Gw Pharma Limited Pharmaceutical compositions comprising cannabigerol
MX2010008706A (es) * 2008-02-06 2010-08-30 Noscira Sa Derivados de fenil-prenilo, de origen marino y sintetico. para el tratamiento de enfermedades o trastornos cognitivos, neurodegenerativos o neuronales.
EP3864000A4 (en) * 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS

Similar Documents

Publication Publication Date Title
JP2022539400A5 (cg-RX-API-DMAC10.html)
JP2022540432A5 (cg-RX-API-DMAC10.html)
JP2022540585A5 (cg-RX-API-DMAC10.html)
JP2022540434A5 (cg-RX-API-DMAC10.html)
JP2023503601A5 (cg-RX-API-DMAC10.html)
JP2022539401A5 (cg-RX-API-DMAC10.html)
JP2022551066A5 (cg-RX-API-DMAC10.html)
JP2022540586A5 (cg-RX-API-DMAC10.html)
JP2023503330A5 (cg-RX-API-DMAC10.html)
JP6813626B2 (ja) グルコシルセラミド合成酵素阻害剤の製造方法
IL287159B1 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
CN113365997A (zh) 作为c-Met抑制剂的含嘧啶基团的三并环类化合物
JP2015516420A5 (cg-RX-API-DMAC10.html)
AR074184A1 (es) Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah
JP2010516635A5 (cg-RX-API-DMAC10.html)
WO2004074297A1 (ja) アミノホスホン酸誘導体とその付加塩及びs1p受容体調節剤
JP2013538198A5 (cg-RX-API-DMAC10.html)
JP2016515096A5 (cg-RX-API-DMAC10.html)
RU2009128062A (ru) Соединения агонисты и антагонисты рецептора сфингозин-1-фосфата
JP2022540433A5 (cg-RX-API-DMAC10.html)
JP2006514925A (ja) アミド化合物および該化合物を用いる方法
WO2005014525A2 (en) Bi-aryl compound having immunosuppressive activity
JP2005015461A5 (cg-RX-API-DMAC10.html)
EA008218B1 (ru) Производные диоксан-2-алкилкарбамата, способ их получения и применение в терапии
JP2023505513A (ja) カンナビノイド誘導体